Thomas M Porter

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Randomized Controlled Trial

Respiratory Syndrome Coronavirus

Top Venues

Healthcare (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Manuela di Fusco, Xiaowu Sun, Kristen E Allen, Alon Yehoshua, Alexandra Berk, Mary B Alvarez, Thomas M Porter, Jinma Ren, Laura Puzniak, Santiago M C Lopez, Joseph Christopher Cappelleri
Effectiveness of BNT162b2 BA.4/5 Bivalent COVID-19 Vaccine against Long COVID Symptoms: A US Nationwide Study. Vaccines 12 (2) (2024)
Manuela di Fusco, Xiaowu Sun, Kristen E Allen, Alon Yehoshua, Alexandra Berk, Mary B Alvarez, Thomas M Porter, Jinma Ren, Laura Puzniak, Santiago M C Lopez, Joseph Christopher Cappelleri
Effectiveness of BNT162b2 BA.4/5 Bivalent COVID-19 Vaccine against Long COVID Symptoms: A US Nationwide Study. Vaccines 12 (2) (2024)
Manuela di Fusco, Joseph C Cappelleri, Laura Anatale-Tardiff, Henriette Coetzer, Alon Yehoshua, Mary B Alvarez, Kristen E Allen, Thomas M Porter, Laura Puzniak, Ashley S Cha-Silva, Santiago M C Lopez, Xiaowu Sun
Impact of COVID-19 Infection on Health-Related Quality of Life, Work Productivity and Activity Impairment by Symptom-Based Long COVID Status and Age in the US. Healthcare (Basel, Switzerland) 11 (20) (2023)